Literature DB >> 19058214

Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina.

Hugo Donato1, Armando Picón, Mónica Martinez, María Cristina Rapetti, Amadeo Rosso, Sergio Gomez, Nestor Rossi, Viviana Bacciedoni, Gabriel Schvartzman, Cecilia Riccheri, Alejandra Costa, Juan Di Santo.   

Abstract

BACKGROUND: Demographics, outcome, and management of idiopathic thrombocytopenic purpura (ITP) in children present differences between countries. Although several factors influence outcome, it is impossible to predict at diagnosis which patients will have acute or chronic disease. High rates of spontaneous remission in chronic ITP have been reported. PROCEDURE: Data concerning 1,683 patients with ITP diagnosed from 1981 to date are presented; outcome was evaluated in 1,418 children.
RESULTS: Remarkable presenting features were an incidence peak in the first 2 years of age and male predominance in patients <24 months of age. Three age groups with different recovery rates (P < 0.001) were established (2-12 months: 89.8%; 1-8 years: 71.3%; 9-18 years: 49.0%). Platelet count <10 x 10(9)/L and history of previous illness were associated with higher remission rates only in patients >12 months of age. The score developed by the NOPHO Group showed a predictive value of 83.9% for acute ITP. Spontaneous remission between 6 months and 11 years from diagnosis was achieved by 107 of 325 (32.9%) non-splenectomized children with chronic ITP, and in 44.9% of them between 6 and 12 months from diagnosis.
CONCLUSIONS: Age and score were main prognostic factors. Infants <1 year of age are a special group with a brief course and very high recovery rate that are not influenced by other prognostic factors. Definition of groups based on age and scoring could be useful to establish differential management guidelines. The cut-off value to define chronic ITP should be changed to 12 months. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19058214     DOI: 10.1002/pbc.21872

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  15 in total

Review 1.  Childhood immune thrombocytopenia: Clinical presentation and management.

Authors:  Mohamed El Faki Osman
Journal:  Sudan J Paediatr       Date:  2012

2.  A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding.

Authors:  Rosarin Sruamsiri; Piyameth Dilokthornsakul; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

3.  Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Annemieke G Laarhoven; Marrie C A Bruin; Barbera Veldhuisen; Sietse Q Nagelkerke; Taco W Kuijpers; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Masja de Haas
Journal:  Blood Adv       Date:  2019-07-09

Review 4.  The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children.

Authors:  Vasile Eduard Roşu; Elena-Lia Spoială; Tamara Solange Roşu; Anca-Viorica Ivanov; Adriana Mocanu; Alecsandra Munteanu; Vasile Valeriu Lupu; Ingrith Miron; Cristina Gavrilovici
Journal:  Front Pediatr       Date:  2022-05-09       Impact factor: 3.569

5.  Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.

Authors:  Yoshihito Morimoto; Nao Yoshida; Nozomu Kawashima; Kimikazu Matsumoto; Koji Kato
Journal:  Int J Hematol       Date:  2014-02-27       Impact factor: 2.490

6.  Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia?

Authors:  Anselm Chi-Wai Lee
Journal:  Singapore Med J       Date:  2018-07       Impact factor: 1.858

7.  Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children.

Authors:  Angela Guarina; Angelica Barone; Assunta Tornesello; Maddalena Marinoni; Giuseppe Lassandro; Paola Giordano; Milena Motta; Marco Spinelli; Ilaria Fontanili; Fiorina Giona; Francesco Menna; Elena Chiocca; Ilaria Fotzi; Angelamaria Petrone; Francesco Graziano; Paola Saracco; Giuseppe Puccio; Michele Citrano; Giovanna Russo; Piero Farruggia
Journal:  J Clin Med       Date:  2021-04-30       Impact factor: 4.241

8.  Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura.

Authors:  Melike Sezgin Evim; Birol Baytan; Adalet Meral Güneş
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

9.  Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Josefina Aparecida Pellegrini Braga; Sandra Regina Loggetto; Andrea Thives de Carvalho Hoepers; Wanderley Marques Bernardo; Leticia Medeiros; Mônica Pinheiro de Almeida Veríssimo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

10.  Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.

Authors:  Hyoung Soo Choi; Mi Hong Ji; Sung Jin Kim; Hyo Seop Ahn
Journal:  Blood Res       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.